glp 1 microdosing THE PCCA BLOG Thinking About Microdosing GLP-1? 5
Description
Conclusion A population pharmacokinetic model incorporating allometric scaling was developed to simultaneously describe the PK of semaglutide in all animal species and predict its PK in humans
Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy
Read the full article covered by Nutritional Outlook here:
We talk to Dr
Then, we will discuss the approaches that can increase the endogenous production of GLP-1 through various stimuli
